BioCentury
ARTICLE | Finance

Diagnostic Domain

Domain continues diagnostics push with Applied Proteomics

September 2, 2013 7:00 AM UTC

While diagnostics are becoming a no-fly zone for many VCs, Domain Associatescontinues to place bets in the space. The firm participated in a $28 million series C round for Applied Proteomics Inc., which is developing blood-based tests that use mass spectrometry to analyze an individual's proteomic signature.

New investor Genting Bhd. led the round, and existing investor Vulcan Capital also participated...